>>> Brexit Min Davis: immediate goal is an agreement on the Brexit implementatio

Brexit Min Davis: immediate goal is an agreement on the Brexit implementation period; confident a political agreement can be reached at the March meeting of EU council 
- The transition period will have a strict time limit 
- Extending Article 50 would not resolve the legal problems around ratifying withdrawal 
- EU and UK are on same page when it comes to need for Brexit transition period 
- We need continued access to each others' markets on current terms; EU and UK must follow the same rules for implementation period for it to work 
- We have to find a way of resolving laws which do not work for Britain
- Speed is key in agreeing on implementation period

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • EGHT +8.4%, INTC +6.1%, DWCH +4.9%, MXIM +4.5%, AVYA +3.3%, ABBV +1.8%, LEA +1.2%, MATW +1.1%, FLEX +1%, COL +0.6%, MSTR +0.5%, FHB +0.5%
M&A news:
  • GST +13.6% (to divest interest in West Edmund Hunton Lime Unit for $107.5 million; expected to close on or before February 28, 2018)
  • VMW +7.2% (Dell (DVMT) considering IPO or purchase of rest of VMW, according to WSJ )
  • AVXS +1.2% (Citigroup called it an interesting take out candidate)
Other news:
  • NVIV +12.8% (enters a common stock purchase agreement with Lincoln Park Capital Fund to sell up to $15 million in shares of common stock)
  • MYO +9.5% (continued strength)
  • EDIT +3% (Adverum Biotech and Editas Medicine announce extension to the cos' collaboration agreement through 3Q18)
  • ADVM +1.6% (Adverum Biotech and Editas Medicine announce extension to the cos' collaboration agreement through 3Q18)
  • NKE +1.4% (higher on reports that Pershing's Bill Ackman discussed investment at client dinner)
  • NWL +1.4% (modestly rebounding from today's 21% decline)
  • AZN +1.4% (reports top-line Phase III KRONOS trial results; demonstrates significant improvement in eight out of nine lung function primary endpoints)
  • TSLA +1.3% (spokesperson has denied issues with Model 3 production)
Analyst comments:
  • ATOS +10.8% (initiated with a Buy at Maxim Group; tgt $2 (stock closed at 0.32 on Thurs))
  • EXPO +2.2% (upgraded to Buy from Hold at SunTrust)
  • GILD +0.9% (upgraded to Buy from Hold at Jefferies)

>>> US Gapping down

Gapping down
In reaction to strong earnings/guidance
:
  • CLFD -16%, SBUX -5%, CL -4.3%, ETFC -3.9%, KLAC -3.6%, HRC -2.2%, TMST -2.1%, ISRG -1.3%, WDC -0.7%
Other news:
  • BIOC -26.6% (prices 33.3 mln shares of common stock at $0.45/share)
  • GDS -5.4% (pricing 8.0 mln ADS offering at $26.00/share)
  • SENS -3.1% (commences offering of convertible senior subordinated notes due 2023, sees Q4 revs of approx. $2.9 mln vs $2.96 mln consensus )
  • SBBP -2.8% (priced 5 million ordinary share offering at $6.75 per share)
  • EQIX -2.7% (CEO Steve Smith to resign; Executive Chairman and former CEO Peter Van Camp appointed interim CEO), .
Analyst comments:
  • BBBY -4.6% (downgraded to Underweight from Neutral at JP Morgan)
  • AZPN -0.9% (downgraded to Underperform from Neutral at BofA/Merrill)

>>> Colgate-Palmolive reported EPS in-line, misses on rev and guided FY18

Colgate-Palmolive reported EPS in-line, misses on rev and guided FY18 (77.31)
  • Reports Q4 (Dec) earnings of $0.75 per share, in-line with the Capital IQ Consensus of $0.75; revenues rose 4.6% year/year to $3.89 bln vs the $3.92 bln Capital IQ Consensus.
  • Global unit volume increased 3.0%, pricing decreased 1.0% and foreign exchange was positive 2.5%. Organic sales (Net sales excluding the impact of foreign exchange, acquisitions and divestments) increased 2.0%.
  • Gross profit margin was 59.8% in fourth quarter 2017 versus 60.4% in fourth quarter 2016. Excluding charges resulting from the Global Growth and Efficiency Program in both periods, Gross profit margin was 60.4% in fourth quarter 2017, a decrease of 40 basis points versus the year ago quarter, as higher raw and packaging material costs and lower pricing were partially offset by cost savings from the Company's funding-the-growth initiatives.
"As we look ahead to 2018, while uncertainty in global markets and category growth worldwide remain challenging, we are maintaining our heightened focus on brand building and increased productivity. Based on current spot rates, we expect a mid-single-digit net sales increase [+4.3%] and low to mid-single-digit organic sales growth in 2018, with improvement in organic sales growth versus the second half of 2017." "Excluding charges resulting from the Global Growth and Efficiency Program and the one-time charge related to U.S. tax reform in 2017, based on current spot rates, we are planning for a year of increased operating cash flow, gross margin expansion, increased advertising investment and low double-digit earnings per share growth [consensus +8.4%], including the impact of U.S. tax reform. Reflecting the U.S. tax reform, we expect our 2018 tax rate to be in the range of 26% to 27%, both on a GAAP basis and excluding the impact of the Global Growth and Efficiency Program."
CL -4% premarke

FT : No, non or nein? The other Brussels Brexit battle

No, non or nein? The other Brussels Brexit battle
Paris thinks EU business could be conducted in French again

Never mind the looming collision between Berlin and Paris over Emmanuel Macron’s expansive plans for the eurozone. Brexit has triggered a more emotionally charged contest. For France, there is something much more important than money at stake — it’s a matter, you could say, of national pride.

Not so long ago, the business of Brussels was conducted in French. Paris thinks it could be so again. The bloc’s rules allow each member state to designate an official EU language. Britain’s departure will leave English without a sponsor on the present list of 24. Ireland and Malta use English at home, but have nominated their mother tongues for EU business.

On the face of it, banishing English is a ludicrous suggestion. It is deeply embedded in the day-to-day work of Europe. On the other hand, there are some determined to extinguish all traces of UK membership from the EU’s institutions. Once removed from the list, English would cease to be one of the bloc’s three working languages. The language of Molière and Proust could be restored to its centuries-old primacy in European diplomacy.

The former communist states of eastern and central Europe take a different view. Pardon our Latin, but they regard English as the de facto lingua franca. Not to put too fine a point on it, the Poles, Czechs and Hungarians have no intention of learning French. Nor will they embrace the EU’s other working language, German. There is too much history there.

As for the political class in Berlin, it is one thing for Mr Macron to demand a eurozone finance minister and budget, quite another to expect the continent’s most powerful nation to give French an advantage over German. Helmut Kohl might once have made such a gesture, but the days when Berlin put the European cause ahead of the German interest have long passed.

The result? A deadlock seemingly as intractable as that over Britain’s future trading relationship with the EU27. Suggestions that Ireland and/or Malta could designate English as well as Gaelic and Maltese are shot down by Francophiles. And it would be too much to expect Dublin or Valetta to jettison their own languages in favour of English.

All may not be lost. The French think the Brexit clock is on their side: that English will lose its legal status at the end of March 2019. Paris, however, may have forgotten the first rule of EU treaties: they can always be reinterpreted by clever lawyers. Officials from the European Commission say that article 342 of the treaties requires a unanimous vote of the council of ministers to change the language regime. To their mind, this means that even when Britain goes, English stays, unless ministers decide otherwise. The ghost of Britain forever stalking the corridors of Brussels? What price French pride?

FT : Kering in talks to end tie-up with Stella McCartney label

Kering in talks to end tie-up with Stella McCartney label
French luxury group weighs sale of 50% holding back to British designer

French luxury group Kering is in talks with Stella McCartney to sell its 50 per cent stake in the eponymous label back to the British fashion designer, according to a person familiar with the discussions.

Stella McCartney and Kering have operated the Stella McCartney brand since 2001 as a 50-50 joint venture. The discussions come as Kering is looking to remould itself as a pure luxury group, announcing this month that it will distribute most of its stake in German sportswear business Puma to shareholders.

A joint statement from Stella McCartney and Kering said: “As often between stakeholders there are regular discussions about the future of the partnership. Any significant change to the current relationship would naturally be made public at the appropriate time.”

Stella McCartney is a small label in the overall context of Kering, which recorded €3.93bn of revenues in the third quarter of 2017. According to the latest accounts for Stella McCartney, sales rose 31 per cent during 2016 to £41.7m, and the label booked a profit of £9.5m. This only reflects its UK business and does not take into account international sales.


The aim of the Puma stock sale is to allow Kering to focus on its higher-margin and faster-growing luxury brands, such as Gucci, Saint Laurent and Balenciaga. It provides them with centralised human resources, marketing and communications functions, while working with individual brands to drive growth. Kering has said it prefers to devote its attention to larger labels, finding that the smaller brands are too much work with too much uncertainty for the pay-off they provide.


Ms McCartney has made ethical fashion a pillar of her label, long before the current vogue for sustainability. A vegetarian, she is known for the use of vegan and animal-free alternatives in her work, and her fur-free approach was recently adopted by Gucci. Last year Ms McCartney launched a debut menswear collection.

She studied fashion design at Central Saint Martins in London and completed an apprenticeship with tailor Edward Sexton, an old friend of her father — Paul McCartney of The Beatles — before taking over from Karl Lagerfeld as creative director at French house Chloé. Ms McCartney launched her own fashion house through the joint venture with Kering.

Kering (then known as PPR) entered the luxury sector in 1999 with the acquisition of a stake in Gucci. Since then it has added other designer labels including Saint Laurent, Bottega Veneta and Balenciaga, and signed partnerships with Alexander McQueen, as well as Stella McCartney.

The discussions over a stake sale were first reported by The Business of Fashion.

>>> AbbVie beats by $0.05, beats on revs; raises FY18 EPS guidance following tax

AbbVie beats by $0.05, beats on revs; raises FY18 EPS guidance following tax reform (108.30)
  • Reports Q4 (Dec) earnings of $1.48 per share, excluding non-recurring items, $0.05 better than the Capital IQ Consensus of $1.43; revenues rose 13.9% year/year to $7.74 bln vs the $7.53 bln Capital IQ Consensus.
  • Global HUMIRA sales increased 14.0 percent on a reported basis, or 12.3 percent operationally, excluding a 1.7 percent favorable impact from foreign exchange. In the U.S., HUMIRA sales grew 15.1 percent in the quarter. Internationally, HUMIRA sales grew 6.5 percent, excluding a 5.2 percent favorable impact from foreign exchange.
  • Co issues raised guidance for FY18, sees EPS of $7.33-7.43 from $6.37-6.57, excluding non-recurring items, vs. $6.66 Capital IQ Consensus Estimate.
  • Co reflects the impact of U.S. tax reform and stronger operating performance. The midpoint of this guidance reflects year-over-year growth of 32 percent, more than half of which is driven by growth in the underlying business. Relative to the previously issued 2018 guidance provided in October 2017, this guidance includes an increase of $0.08 as a result of stronger operating dynamics. AbbVie's adjusted EPS guidance range reflects an effective tax rate of approximately 9 percent in 2018.
  • In 2018, AbbVie will experience a one-time net tax benefit related to the timing of the phase in of provisions of the new legislation on certain subsidiaries. This benefit has been excluded from the adjusted EPS guidance, and included in the GAAP guidance range.
  • Over the next five years, AbbVie plans to invest approximately $2.5 billion in capital projects in the U.S. and the company is currently evaluating additional expansion of its U.S. facilities. Also, in 2018, the company plans to make a one-time charitable contribution of approximately $350 million to select not-for-profit organizations based in the United States

>>> Intel: Color on the Qtr -->+5.75% @ 47.90

Intel: Color on the Qtr -- > +5.75% @ 47.90

* Mizuho Securities notes that INTC continued strength moving into 2018, expecting to be up high single-digits. Intel noted it was addressing the security concerns with Meltdown and Spectre and continues to see no material financial impact. Raising their estimates, reiterating their Buy and raising their PT to $52, as they see a slow meltup with Data Center stronger and a tailwind with from lower taxes, higher dividends and an attractive valuation.
* FB Riley notes that 4Q's biggest surprise was Data Center's large upside, while a material PC beat essentially matched their preview. They are encouraged that following steady outperformance to C17's financial targets, C18 starts with an above-Street +3.5% y/y growth target, although with $3.55 in EPS a bit below the Street. On the plus side, they like 4Q's DCG-led revenue beat, significant GM upside, a much larger-than expected tax rate reduction to 14.0%, and a +10% dividend boost. Alternatively, 1Q's -12.0% q/q sales decline will fuel Bearish "peak cycle" concerns while C18 GM are lower than they previously expected due to higher 10nm fab start-up expense. C18's capex view is $14.0B/+22.0% y/ y, a much larger-than-expected increase driven by Memory and less so Logic. Risks persist such as AMD competitive inroads but they are encouraged with C17's execution and suspect conservatism in C18's targets. Their C18/19 PF EPS tick $0.04 and $0.39 higher, respectively to $3.54 and $4.29. Valuation is 13.3x and 11.0x these estimates, an attractive entry point in their view. Thier PT ticks up from $53.00 to $55.00 and they retain a Buy rating on value-oriented INTC shares.

>>> Early premarket gappers

Early premarket gappers
Gapping up:
  • GST +13.6%, MYO +12.4%, EGHT +7.1%, INTC +5.4%, DWCH +4.9%, MXIM +4.5%, AVP +3.8%, AVYA +3.3%, EDIT +3.1%, ADVM +1.6%, WRLD +1.4%, TSLA +1.3%, NKE +1.3%, AZN +1.2%, MATW +1.1%, FLEX +1%, NWL +0.8%, MSTR +0.5%, FHB +0.5%
Gapping down:
  • CLFD -16%, SBUX -4.8%, TMST -4.7%, ETFC -3.9%, ISRG -3.3%, SENS -3.1%, CL -3.1%, SBBP -2.8%, EQIX -2.7%, SIVB -2.3%, WDC -1.7%, RPD -1.4%, HON -1.4%, KLAC -1.1%, TAHO -0.7%, PKI -0.7%, TTPH -0.6%